Brief: Eton Pharmaceuticals Q2 Net Income USD -3.041 Million
08/08/2024 21:01
Aug 08 (Reuters) - Eton Pharmaceuticals Q2 EPS USD -0.12. * Q2 basic EPS USD -0.12
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer